Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 14396-16-8
2. Piperazine 2-hydroxypropane-1,2,3-tricarboxylate
3. 2-hydroxypropane-1,2,3-tricarboxylic Acid;piperazine
4. Piperazinecitrate
5. Oxyzin (syrup)
6. Piperazine Citrate (1:1)
7. Schembl125278
8. Dtxsid20921081
9. Amy40769
10. Nsc86779
11. Piperazine Compound With Citric Acid
12. Nsc203336
13. Akos015920444
14. Gs-3869
15. Nsc-203336
16. Piperazine,2,3-propanetricarboxylate (3:2)
17. E75921
18. A808202
19. 2-hydroxypropane-1,2,3-tricarboxylic Acid--piperazine (1/1)
20. Wln: T6m Dmtj & 3 & 622 & Qv1xqvq1vq & 2 & 621
21. 113484-97-2
Molecular Weight | 278.26 g/mol |
---|---|
Molecular Formula | C10H18N2O7 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 5 |
Exact Mass | 278.11140092 g/mol |
Monoisotopic Mass | 278.11140092 g/mol |
Topological Polar Surface Area | 156 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 254 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
RLD : No
TE Code :
Brand Name : BRYREL
Dosage Form : SYRUP;ORAL
Dosage Strength : EQ 500MG BASE/5ML
Approval Date : 1982-01-01
Application Number : 17796
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : PIPERAZINE CITRATE
Dosage Form : SYRUP;ORAL
Dosage Strength : EQ 500MG BASE/5ML
Approval Date : 1982-01-01
Application Number : 80774
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : MULTIFUGE
Dosage Form : SYRUP;ORAL
Dosage Strength : EQ 500MG BASE/5ML
Approval Date : 1982-01-01
Application Number : 9452
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : ANTEPAR
Dosage Form : SYRUP;ORAL
Dosage Strength : EQ 500MG BASE/5ML
Approval Date : 1982-01-01
Application Number : 9102
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : ANTEPAR
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 500MG BASE
Approval Date : 1982-01-01
Application Number : 9102
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : PIPERAZINE CITRATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 250MG BASE
Approval Date : 1982-01-01
Application Number : 80874
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : PIPERAZINE CITRATE
Dosage Form : SYRUP;ORAL
Dosage Strength : EQ 500MG BASE/5ML
Approval Date : 1982-01-01
Application Number : 80963
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : PIPERAZINE CITRATE
Dosage Form : SYRUP;ORAL
Dosage Strength : EQ 500MG BASE/5ML
Approval Date : 1982-01-01
Application Number : 80671
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : VERMIDOL
Dosage Form : SYRUP;ORAL
Dosage Strength : EQ 500MG BASE/5ML
Approval Date : 1982-01-01
Application Number : 80992
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Related Excipient Companies
Excipients by Applications
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
31
PharmaCompass offers a list of Piperazine Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Piperazine Citrate manufacturer or Piperazine Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Piperazine Citrate manufacturer or Piperazine Citrate supplier.
PharmaCompass also assists you with knowing the Piperazine Citrate API Price utilized in the formulation of products. Piperazine Citrate API Price is not always fixed or binding as the Piperazine Citrate Price is obtained through a variety of data sources. The Piperazine Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oxyzin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxyzin, including repackagers and relabelers. The FDA regulates Oxyzin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxyzin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxyzin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxyzin supplier is an individual or a company that provides Oxyzin active pharmaceutical ingredient (API) or Oxyzin finished formulations upon request. The Oxyzin suppliers may include Oxyzin API manufacturers, exporters, distributors and traders.
click here to find a list of Oxyzin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxyzin written confirmation (Oxyzin WC) is an official document issued by a regulatory agency to a Oxyzin manufacturer, verifying that the manufacturing facility of a Oxyzin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxyzin APIs or Oxyzin finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxyzin WC (written confirmation) as part of the regulatory process.
click here to find a list of Oxyzin suppliers with Written Confirmation (WC) on PharmaCompass.
Oxyzin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxyzin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxyzin GMP manufacturer or Oxyzin GMP API supplier for your needs.
A Oxyzin CoA (Certificate of Analysis) is a formal document that attests to Oxyzin's compliance with Oxyzin specifications and serves as a tool for batch-level quality control.
Oxyzin CoA mostly includes findings from lab analyses of a specific batch. For each Oxyzin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxyzin may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxyzin EP), Oxyzin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxyzin USP).